Cargando…

Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients

BACKGROUND: Increased catabolism has recently been recognized as a clinical manifestation of amyotrophic lateral sclerosis (ALS). The hypothalamic systems have been shown to be involved in the metabolic dysfunction in ALS, but the exact extent of hypothalamic circuit alterations in ALS is yet to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayer, David, Antonucci, Stefano, Müller, Hans-Peter, Saad, Rami, Dupuis, Luc, Rasche, Volker, Böckers, Tobias M., Ludolph, Albert C., Kassubek, Jan, Roselli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168014/
https://www.ncbi.nlm.nih.gov/pubmed/34059131
http://dx.doi.org/10.1186/s40035-021-00241-6
_version_ 1783701802812702720
author Bayer, David
Antonucci, Stefano
Müller, Hans-Peter
Saad, Rami
Dupuis, Luc
Rasche, Volker
Böckers, Tobias M.
Ludolph, Albert C.
Kassubek, Jan
Roselli, Francesco
author_facet Bayer, David
Antonucci, Stefano
Müller, Hans-Peter
Saad, Rami
Dupuis, Luc
Rasche, Volker
Böckers, Tobias M.
Ludolph, Albert C.
Kassubek, Jan
Roselli, Francesco
author_sort Bayer, David
collection PubMed
description BACKGROUND: Increased catabolism has recently been recognized as a clinical manifestation of amyotrophic lateral sclerosis (ALS). The hypothalamic systems have been shown to be involved in the metabolic dysfunction in ALS, but the exact extent of hypothalamic circuit alterations in ALS is yet to be determined. Here we explored the integrity of large-scale cortico-hypothalamic circuits involved in energy homeostasis in murine models and in ALS patients. METHODS: The rAAV2-based large-scale projection mapping and image analysis pipeline based on Wholebrain and Ilastik software suites were used to identify and quantify projections from the forebrain to the lateral hypothalamus in the SOD1(G93A) ALS mouse model (hypermetabolic) and the Fus(ΔNLS) ALS mouse model (normo-metabolic). 3 T diffusion tensor imaging (DTI)-magnetic resonance imaging (MRI) was performed on 83 ALS and 65 control cases to investigate cortical projections to the lateral hypothalamus (LHA) in ALS. RESULTS: Symptomatic SOD1(G93A) mice displayed an expansion of projections from agranular insula, ventrolateral orbitofrontal and secondary motor cortex to the LHA. These findings were reproduced in an independent cohort by using a different analytic approach. In contrast, in the Fus(ΔNLS) ALS mouse model hypothalamic inputs from insula and orbitofrontal cortex were maintained while the projections from motor cortex were lost. The DTI-MRI data confirmed the disruption of the orbitofrontal-hypothalamic tract in ALS patients. CONCLUSION: This study provides converging murine and human data demonstrating the selective structural disruption of hypothalamic inputs in ALS as a promising factor contributing to the origin of the hypermetabolic phenotype. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40035-021-00241-6.
format Online
Article
Text
id pubmed-8168014
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81680142021-06-02 Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients Bayer, David Antonucci, Stefano Müller, Hans-Peter Saad, Rami Dupuis, Luc Rasche, Volker Böckers, Tobias M. Ludolph, Albert C. Kassubek, Jan Roselli, Francesco Transl Neurodegener Research BACKGROUND: Increased catabolism has recently been recognized as a clinical manifestation of amyotrophic lateral sclerosis (ALS). The hypothalamic systems have been shown to be involved in the metabolic dysfunction in ALS, but the exact extent of hypothalamic circuit alterations in ALS is yet to be determined. Here we explored the integrity of large-scale cortico-hypothalamic circuits involved in energy homeostasis in murine models and in ALS patients. METHODS: The rAAV2-based large-scale projection mapping and image analysis pipeline based on Wholebrain and Ilastik software suites were used to identify and quantify projections from the forebrain to the lateral hypothalamus in the SOD1(G93A) ALS mouse model (hypermetabolic) and the Fus(ΔNLS) ALS mouse model (normo-metabolic). 3 T diffusion tensor imaging (DTI)-magnetic resonance imaging (MRI) was performed on 83 ALS and 65 control cases to investigate cortical projections to the lateral hypothalamus (LHA) in ALS. RESULTS: Symptomatic SOD1(G93A) mice displayed an expansion of projections from agranular insula, ventrolateral orbitofrontal and secondary motor cortex to the LHA. These findings were reproduced in an independent cohort by using a different analytic approach. In contrast, in the Fus(ΔNLS) ALS mouse model hypothalamic inputs from insula and orbitofrontal cortex were maintained while the projections from motor cortex were lost. The DTI-MRI data confirmed the disruption of the orbitofrontal-hypothalamic tract in ALS patients. CONCLUSION: This study provides converging murine and human data demonstrating the selective structural disruption of hypothalamic inputs in ALS as a promising factor contributing to the origin of the hypermetabolic phenotype. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40035-021-00241-6. BioMed Central 2021-05-31 /pmc/articles/PMC8168014/ /pubmed/34059131 http://dx.doi.org/10.1186/s40035-021-00241-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Bayer, David
Antonucci, Stefano
Müller, Hans-Peter
Saad, Rami
Dupuis, Luc
Rasche, Volker
Böckers, Tobias M.
Ludolph, Albert C.
Kassubek, Jan
Roselli, Francesco
Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients
title Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients
title_full Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients
title_fullStr Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients
title_full_unstemmed Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients
title_short Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients
title_sort disruption of orbitofrontal-hypothalamic projections in a murine als model and in human patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168014/
https://www.ncbi.nlm.nih.gov/pubmed/34059131
http://dx.doi.org/10.1186/s40035-021-00241-6
work_keys_str_mv AT bayerdavid disruptionoforbitofrontalhypothalamicprojectionsinamurinealsmodelandinhumanpatients
AT antonuccistefano disruptionoforbitofrontalhypothalamicprojectionsinamurinealsmodelandinhumanpatients
AT mullerhanspeter disruptionoforbitofrontalhypothalamicprojectionsinamurinealsmodelandinhumanpatients
AT saadrami disruptionoforbitofrontalhypothalamicprojectionsinamurinealsmodelandinhumanpatients
AT dupuisluc disruptionoforbitofrontalhypothalamicprojectionsinamurinealsmodelandinhumanpatients
AT raschevolker disruptionoforbitofrontalhypothalamicprojectionsinamurinealsmodelandinhumanpatients
AT bockerstobiasm disruptionoforbitofrontalhypothalamicprojectionsinamurinealsmodelandinhumanpatients
AT ludolphalbertc disruptionoforbitofrontalhypothalamicprojectionsinamurinealsmodelandinhumanpatients
AT kassubekjan disruptionoforbitofrontalhypothalamicprojectionsinamurinealsmodelandinhumanpatients
AT rosellifrancesco disruptionoforbitofrontalhypothalamicprojectionsinamurinealsmodelandinhumanpatients